Viewing Study NCT03165734


Ignite Creation Date: 2025-12-25 @ 2:20 AM
Ignite Modification Date: 2025-12-28 @ 12:00 AM
Study NCT ID: NCT03165734
Status: RECRUITING
Last Update Posted: 2025-10-14
First Post: 2017-05-17
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase 3 Study of Pacritinib in Patients With Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis
Sponsor: Swedish Orphan Biovitrum
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module